Erratum: The ICON and AGO Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial (Lancet (2003) 361 (2099-106))

J. A. Lendermann, N. Colombo, A. Du Bois, V. Torri, I. Floriani, W. Qian, H. P. Adams, M. K B Parmar, S. Collins, S. Wheeler, D. Poli, M. Santillo, A. Buda, G. Elser, P. Schantl

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1504
Number of pages1
JournalLancet
Volume362
Issue number9394
DOIs
Publication statusPublished - Nov 1 2003

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Erratum : The ICON and AGO Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial (Lancet (2003) 361 (2099-106)). / Lendermann, J. A.; Colombo, N.; Du Bois, A.; Torri, V.; Floriani, I.; Qian, W.; Adams, H. P.; Parmar, M. K B; Collins, S.; Wheeler, S.; Poli, D.; Santillo, M.; Buda, A.; Elser, G.; Schantl, P.

In: Lancet, Vol. 362, No. 9394, 01.11.2003, p. 1504.

Research output: Contribution to journalArticle

Lendermann, J. A. ; Colombo, N. ; Du Bois, A. ; Torri, V. ; Floriani, I. ; Qian, W. ; Adams, H. P. ; Parmar, M. K B ; Collins, S. ; Wheeler, S. ; Poli, D. ; Santillo, M. ; Buda, A. ; Elser, G. ; Schantl, P. / Erratum : The ICON and AGO Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial (Lancet (2003) 361 (2099-106)). In: Lancet. 2003 ; Vol. 362, No. 9394. pp. 1504.
@article{bfa32a3e934444bfbdc7688766920f9b,
title = "Erratum: The ICON and AGO Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial (Lancet (2003) 361 (2099-106))",
author = "Lendermann, {J. A.} and N. Colombo and {Du Bois}, A. and V. Torri and I. Floriani and W. Qian and Adams, {H. P.} and Parmar, {M. K B} and S. Collins and S. Wheeler and D. Poli and M. Santillo and A. Buda and G. Elser and P. Schantl",
year = "2003",
month = "11",
day = "1",
doi = "10.1016/S0140-6736(03)14711-3",
language = "English",
volume = "362",
pages = "1504",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Publishing Group",
number = "9394",

}

TY - JOUR

T1 - Erratum

T2 - The ICON and AGO Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial (Lancet (2003) 361 (2099-106))

AU - Lendermann, J. A.

AU - Colombo, N.

AU - Du Bois, A.

AU - Torri, V.

AU - Floriani, I.

AU - Qian, W.

AU - Adams, H. P.

AU - Parmar, M. K B

AU - Collins, S.

AU - Wheeler, S.

AU - Poli, D.

AU - Santillo, M.

AU - Buda, A.

AU - Elser, G.

AU - Schantl, P.

PY - 2003/11/1

Y1 - 2003/11/1

UR - http://www.scopus.com/inward/record.url?scp=0242361268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242361268&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(03)14711-3

DO - 10.1016/S0140-6736(03)14711-3

M3 - Article

AN - SCOPUS:0242361268

VL - 362

SP - 1504

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9394

ER -